|
Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partner
The Board of Directors of Ipsen, chaired by Jean-Luc Bélingard, met on 26 February 2010 to review the Group’s results for 2009, published today.
More... |
| All times are GMT -7. The time now is 07:00 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021